Free Case Evaluation
Connect
With Us

J&J’ Deceptive Practices Brings $33 Mil Fine

Alex Gorsky, CEO J&J

Mesh Medical Device News Desk, May 25, 2017 ~ For years, the healthcare giant has faced scrutiny over the cleanliness of its plants that produce its over-the-counter products.  

Now J&J must pay $33 million over its “deceptive practices.”

Fierce Pharma breaks the story this afternoon (here) of the $33 million fine Johnson & Johnson has agreed to pay over its recall of millions of bottles of over-the-counter children’s medicines and the substandard plants they came from.

J&M will pay the money to 42 states and the District of Columbia after an agreement with the New York Attorney General’s office.  The company must also reform its marketing practices. See it here. 

Years ago, Food and Drug Administration inspectors found contamination in the vats that produced Children’s Tylenol and Motrin, including metal particles, reports Time.com.

That led to a recall  in 2010 of over-the-counter products including Infants’ Tylenol and Children’s Motrin.   Here is a list of the items that were recalled.

In 2008 to 2010, millions of bottles of Tylenol, Motrin, Benadryl and other products made under the McNeil Consumer Healthcare banner. Not only metal particles but mold and labeling problems plagued the products.

As part of the agreement, J&J and its McNeil division, cannot say that its products meet acceptable Good Manufacturing Practices if a quality recall occurred over the past year.

Just two weeks ago, J&J resolved a similar case in the state of Oregon for $400,000. In that instance, J&J failed to announce a recall and instead sent undercover contractors into stores to retrieve the defective medications so the public wouldn’t know.

In 2008, the Food and Drug Administration conducted a series of inspections finding the Fort Washington, Pennsylvania plant found particulate contamination in the products. McNeil pled guilty and paid a $25 million fine.

Since then, the Pennsylvania plant has undergone $100 million in upgrades and reopened after it was shuttered by the FDA. ##

6 Comments

  1. Terri L says:

    I have had 2 hernia surgeries. I’m now in pain management. When I was referred to pain management I was prescribed 4 pills a day. I went to an appt one day and was told the doctor read something in a magazine so he changed it to 3 pills a day. Im being prescribed from something out of a magazine not by what i need for my pain. The last hernia surgery I had the doctor said I was full of adhesions and my insides weren’t where they should be. I’ve had to close my business I have a lot of the problems that I understand are because of this mesh issue. I’m so frustrated I don’t know what to do anymore.

    • Kitty says:

      Hi Terri. I think that is the NEW RX used for pain management…3 Opiods per day. 3 per day will make u just as dependent as 4 per day..

  2. Never the Same says:

    Where does that money go? Can it help victims?

    • Jane Akre says:

      It gets divided among the law firms…. those who did the most work, or are best positioned get the most.

  3. diva64 says:

    Lupus I have just been informed by my attorneys office is not a complication of mesh, I told him studies were definitely linking it as a effect of Mesh, that they need to look at the data.
    I did not agree to anything offered and told my attorneys that the women would be very foolish to do so….This might not be the exact place to state this however I felt many Mesh patients would see it here.

    • Anne says:

      Same, same! Autoimmune diseases all new dice implant/explants! Not functioning well so my 1099 income has been zilch. Will NOT settle unless it’s reasonable…50% of what average jurors have awarded in my state. equal a min in 7 figures. Attorney is not negotiating well in my behalf. Feel like they work for the Mesh company.

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*

© 2016 - 2017 Mesh Newsdesk. All rights reserved.
This news website is designed by NextClient.com.